What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 4.3% in the morning session after its key ...

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

Eli Lilly and Company (NYSE:LLY) is one of the Top 10 Stocks Wall Street is Buzzing About These Days. Talking about Morgan ...

Through an analysis of Eli Lilly, we can infer the following trends: At 86.87, the stock's Price to Earnings ratio significantly exceeds the industry average by 3.52x, suggesting a premium ...

Eli Lilly's stock isn't cheap The company's stock trades at a hefty 39 times forward earnings. That's very high for a pharma company and more than twice its main GLP-1 competitor, Novo Nordisk.

Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance Eli Lilly sees FY24 EPS $12.20-$12.70, consensus $12.43 Eli Lilly reports Q4 EPS $2.49, consensus $2.19 ...

Eli Lilly is serving a market that may reach $100 billion. Eli Lilly (LLY 0.16%) stock has soared 90% over the past year, a huge gain for a pharmaceutical company.

The stock’s shares went for about $868 in early June, up more than 93 percent over the last year. Bottom line Eli Lilly’s stock price is riding a wave of optimism and strong earnings.

However, when looking at the fundamental performance of these two, I don’t see many reasons for the stock outperformance of Eli Lilly. At best, we can call it a head-to-head race.

Eli Lilly (NYSE:LLY) is scheduled to release its earnings report on Thursday, May 1, 2025. For event-driven traders, historical stock performance following earnings announcements may offer ...